In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
QUEST DIAGNOSTICS ACQUIRES PATHWAY DIAGNOSTICS TO EXPAND BIOMARKER AND ONCOLOGY TESTING
Cardinal Health, Quest Diagnostics Sign Prime-Vendor Agreement for Laboratory Products
Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics
Epigenomics AG Licenses Biomarker for Development of Prostate Cancer Test to Quest Diagnostics
Quest Diagnostics and Celera Diagnostics to collaborate